- Home
- AMPS vs CRMD Comparison
AMPS vs CRMD Comparison
Compare AMPS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPS
- CRMD
- Stock Information
- Founded
- AMPS 2009
- CRMD 2006
- Country
- AMPS United States
- CRMD United States
- Employees
- AMPS N/A
- CRMD N/A
- Industry
- AMPS Electric Utilities: Central
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- AMPS Utilities
- CRMD Health Care
- Exchange
- AMPS Nasdaq
- CRMD Nasdaq
- Market Cap
- AMPS 608.0M
- CRMD 753.6M
- IPO Year
- AMPS N/A
- CRMD 2010
- Fundamental
- Price
- AMPS $3.96
- CRMD $10.15
- Analyst Decision
- AMPS Strong Buy
- CRMD Strong Buy
- Analyst Count
- AMPS 9
- CRMD 6
- Target Price
- AMPS $5.38
- CRMD $15.67
- AVG Volume (30 Days)
- AMPS 1.1M
- CRMD 1.5M
- Earning Date
- AMPS 03-13-2025
- CRMD 03-11-2025
- Dividend Yield
- AMPS N/A
- CRMD N/A
- EPS Growth
- AMPS N/A
- CRMD N/A
- EPS
- AMPS 0.22
- CRMD N/A
- Revenue
- AMPS $185,992,000.00
- CRMD $12,262,234.00
- Revenue This Year
- AMPS $30.74
- CRMD N/A
- Revenue Next Year
- AMPS $17.00
- CRMD $246.41
- P/E Ratio
- AMPS $17.86
- CRMD N/A
- Revenue Growth
- AMPS 25.90
- CRMD 41184.20
- 52 Week Low
- AMPS $2.71
- CRMD $2.89
- 52 Week High
- AMPS $7.28
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- AMPS 51.87
- CRMD 40.80
- Support Level
- AMPS $3.60
- CRMD $11.90
- Resistance Level
- AMPS $4.14
- CRMD $12.67
- Average True Range (ATR)
- AMPS 0.26
- CRMD 0.73
- MACD
- AMPS 0.02
- CRMD -0.27
- Stochastic Oscillator
- AMPS 70.53
- CRMD 2.12
About AMPS Altus Power Inc.
Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serve commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Their primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.